Home › Funds › Emerald Investment Advisers, LLC › LGND
Emerald Investment Advisers, LLC position in LGND
LIGAND PHARMACEUTICALS · Health Care
Emerald Investment Advisers, LLC reported holding 40,760 shares of LGND (LIGAND PHARMACEUTICALS) in its Q3 2026 13F filing — a position valued at US$12.7M, representing 0.88% of its reported portfolio and ranking #16 among its reported holdings. Emerald Investment Advisers, LLC has disclosed LGND holdings in 3 of the last 3 reported quarters, going back to Q1 2026.
Last updated: 2026-11-09 · Source: SEC EDGAR Form 13F-HR
How Emerald Investment Advisers, LLC's LGND position evolved
Emerald Investment Advisers, LLC first disclosed a stake in LGND in Q1 2026 at 44,226 shares (US$8.8M). The position peaked in Q2 2026 at 46,921 shares, worth US$14.8M. Across 3 filings, Emerald Investment Advisers, LLC increased the stake 1 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 40,760 shares valued at US$12.7M — a reduction of -6,161 shares quarter over quarter..
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2026 | 44.23K | $8.83M | New |
| Q2 2026 | 46.92K | $14.83M | Add |
| Q3 2026 | 40.76K | $12.73M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About LGND and 13F data
LGND (LIGAND PHARMACEUTICALS) is a Health Care company. 58 other funds we track also report a position in LGND — the largest reported positions include CONGRESS ASSET MANAGEMENT CO (US$205.7M), Chicago Capital, LLC (US$172.2M), Stephens Investment Management Group LLC (US$150.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding LGND
- CONGRESS ASSET MANAGEMENT CO 658.56K sh · $205.71M · Q3 2026
- Chicago Capital, LLC 551.23K sh · $172.19M · Q3 2026
- Stephens Investment Management Group LLC 475.61K sh · $150.34M · Q2 2026
- RICE HALL JAMES & ASSOCIATES, LLC 270.05K sh · $85.36M · Q2 2026
- Ranger Investment Management, L.P. 257.60K sh · $81.42M · Q2 2026
- GW&K Investment Management, LLC 246.88K sh · $78.04M · Q2 2026
- NEXT CENTURY GROWTH INVESTORS LLC 198.54K sh · $62.76M · Q2 2026
- ASHFORD CAPITAL MANAGEMENT INC 170.24K sh · $53.81M · Q2 2026
- Private Capital Management, LLC 166.02K sh · $52.48M · Q2 2026
- VILLERE ST DENIS J & CO LLC 155.51K sh · $49.15M · Q2 2026
- Granahan Investment Management, LLC 147.23K sh · $46.54M · Q2 2026
- Penn Capital Management Company, LLC 100.34K sh · $31.75M · Q2 2026
More on Emerald Investment Advisers, LLC
FAQ
How long has Emerald Investment Advisers, LLC held LGND?
Emerald Investment Advisers, LLC has disclosed LGND holdings in 3 of the last 3 reported quarters, going back to Q1 2026.
What is Emerald Investment Advisers, LLC's current position in LGND?
As of Q3 2026, Emerald Investment Advisers, LLC holds 40.76K shares of LGND (LIGAND PHARMACEUTICALS), valued at $12.73M, representing 0.88% of its reported portfolio and ranking #16.
Has Emerald Investment Advisers, LLC been buying or selling LGND?
In the latest 13F filing (Q3 2026), Emerald Investment Advisers, LLC reduced its position in LGND. The position peaked in Q2 2026 at 46.92K shares.
Which other funds hold LGND?
Other major institutional holders of LGND include CONGRESS ASSET MANAGEMENT CO, Chicago Capital, LLC, Stephens Investment Management Group LLC, among 58 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.